Ahmed O Elzoghby
Overview
Explore the profile of Ahmed O Elzoghby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Atallah M, Sallam M, Abdelmoneem M, Teleb M, Elkhodairy K, Bekhit A, et al.
Colloids Surf B Biointerfaces
. 2022 Jul;
217:112657.
PMID: 35803031
The current treatment protocols for breast cancer have shifted from single agent therapies to combinatorial approaches that offer synergistic efficacies and reduced side effects. Self-assembled nanogels comprising natural polysaccharides and...
12.
Mokhtar S, Khattab S, Elkhodairy K, Teleb M, Bekhit A, Elzoghby A, et al.
Front Chem
. 2022 Apr;
10:847573.
PMID: 35392419
While the treatment regimen of certain types of breast cancer involves a combination of hormonal therapy and chemotherapy, the outcomes are limited due to the difference in the pharmacokinetics of...
13.
Hafez D, Hassanin I, Teleb M, Khattab S, Elkhodairy K, Elzoghby A
Nanomedicine (Lond)
. 2021 Sep;
16(25):2305-2325.
PMID: 34551585
Histone deacetylase inhibitors (HDACi) are cancer therapeutics that operate at the epigenetic level and which have recently gained wide attention. However, the applications of HDACi are generally hindered by their...
14.
Khafaga A, Shamma R, Abdeen A, Barakat A, Noreldin A, Elzoghby A, et al.
Nanomedicine (Lond)
. 2021 Jul;
16(19):1691-1712.
PMID: 34264123
While cancer remains a significant global health problem, advances in cancer biology, deep understanding of its underlaying mechanism and identification of specific molecular targets allowed the development of new therapeutic...
15.
Anwar D, El-Sayed M, Reda A, Fang J, Khattab S, Elzoghby A
Expert Opin Drug Deliv
. 2021 Jul;
18(11):1609-1625.
PMID: 34254868
: The use of herbal compounds in cancer therapy has great potential to promote the efficacy of current cancer therapeutic strategies. Herbal compounds were successfully reported to enhance tumor cells...
16.
Abdelhamid A, Zayed D, Heikal L, Khattab S, Mady O, El-Gizawy S, et al.
Nanomedicine (Lond)
. 2021 Jun;
16(18):1613-1625.
PMID: 34189946
Polymeric nanocapsules are vesicular drug-delivery systems composed of an inner oily reservoir surrounded by polymeric membranes. Nanocapsules have various advantages over other nanovesicular systems such as providing controlled drug release...
17.
Metawea O, Abdelmoneem M, Haiba N, Khalil H, Teleb M, Elzoghby A, et al.
Colloids Surf B Biointerfaces
. 2021 Mar;
202:111694.
PMID: 33740633
Despite the active research towards introducing novel anticancer agents, the long-term sequelae and side effects of chemotherapy remain the major obstacle to achieving clinical success. Recent cancer research is now...
18.
Abdelaziz H, Elzoghby A, Helmy M, Abdelfattah E, Fang J, Samaha M, et al.
ACS Biomater Sci Eng
. 2021 Jan;
6(2):1030-1042.
PMID: 33464839
Localized drug delivery to lung cancer can overcome the limitations of systemic nanocarriers including low drug amounts reaching lung tissues and severe off-target toxicity. The current work presented novel inhalable...
19.
Kamel N, Helmy M, Abdelfattah E, Khattab S, Ragab D, Samaha M, et al.
ACS Biomater Sci Eng
. 2021 Jan;
6(1):71-87.
PMID: 33463208
Localized pulmonary delivery of anticancer agents to lungs has proven to be pioneering approach for lung cancer therapy. Hybrid lipid nanocore-protein shell nanoparticles (HLPNPs) coloaded with all-trans retinoic acid (ATRA)...
20.
Rofeal M, Elzoghby A, Helmy M, Khalil R, Khairy H, Omar S
ACS Biomater Sci Eng
. 2020 Dec;
6(10):5685-5699.
PMID: 33320553
In view of the promising applications of nanoparticles in drug delivery, this study highlights the fabrication of new bioactive green protein-polysaccharide nanocomplexes with significant antibacterial and antitumor efficacies. We preformulated...